Monte Rosa Therapeutics, Inc. (GLUE)
Market Open
1 Sep, 19:44
NASDAQ (NGS) NASDAQ (NGS) Primary $
14. 21
+0.27
+1.9268%
$
1.18B Market Cap
- P/E Ratio
- Div Yield
526,887 Volume
-2.4 Eps
$ 13.94
Previous Close 
Want to track GLUE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.57 |
| | | 0.03 | 0.27 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
GLUE Earnings Reports FAQ
What is the earnings per share (EPS) for GLUE?
The current EPS is -2.4.
What is the company's earnings growth rate?
Monte Rosa Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Monte Rosa Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Monte Rosa Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for GLUE at this time, as Monte Rosa Therapeutics, Inc has no recent EPS data to calculate it.
